198 related articles for article (PubMed ID: 1164059)
21. Prophylactic hyperthermic limb perfusion in stage I melanoma.
Krige JE; King HS; Strover RM
Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
[TBL] [Abstract][Full Text] [Related]
22. [Surgical treatment and regional chemotherapy in melanoma of the extremities].
Henneking K; Binder J; Weyers W; Schwemmle K
Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350
[TBL] [Abstract][Full Text] [Related]
23. [Clinical results of extremity perfusion in malignant melanoma].
Huber R; Stützer H; Krüger I
Zentralbl Chir; 1996; 121(3):234-42. PubMed ID: 8867351
[TBL] [Abstract][Full Text] [Related]
24. Perfusion therapy for extremity melanoma.
Brown AS; Wallack MK; Horstmann JT; Hamilton RW; Johnson JL; Rosato FE
Arch Surg; 1976 Sep; 111(9):961-3. PubMed ID: 949257
[TBL] [Abstract][Full Text] [Related]
25. Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermic isolation perfusion, wide excision, and regional lymphadenectomy.
Fletcher JR; White CR; Fletcher WS
Am J Surg; 1986 May; 151(5):593-8. PubMed ID: 3518512
[TBL] [Abstract][Full Text] [Related]
26. Local recurrence and survival in patients with (Clark Level IV/V and over 1.5-mm thickness) stage I malignant melanoma of the extremities after regional perfusion.
Schraffordt Koops H; Beekhuis H; Oldhoff J; Oosterhuis JW; van der Ploeg E; Vermey A
Cancer; 1981 Nov; 48(9):1952-7. PubMed ID: 7296506
[TBL] [Abstract][Full Text] [Related]
27. Isolated regional perfusion in the treatment of malignant melanomas of the extremities.
Schraffordt Koops H; Oldhoff J; van der Ploeg E; Vermey A; Eibergen R
Arch Chir Neerl; 1975; 27(4):237-43. PubMed ID: 1211947
[TBL] [Abstract][Full Text] [Related]
28. Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.
Schraffordt Koops H; Kroon BB; Oldhoff J; Hoekstra HJ
World J Surg; 1992; 16(2):241-5. PubMed ID: 1561805
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous melanoma: a twenty-year retrospective study with clinicopathologic correlation.
Franklin JD; Reynolds VH; Page DL
Plast Reconstr Surg; 1975 Sep; 56(3):277-85. PubMed ID: 1153544
[TBL] [Abstract][Full Text] [Related]
30. Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases.
Deroose JP; Grünhagen DJ; Eggermont AM; Verhoef C
Melanoma Res; 2015 Oct; 25(5):427-31. PubMed ID: 26110555
[TBL] [Abstract][Full Text] [Related]
31. Isolated limb perfusion for stage I melanoma of the extremity: a comparison of melphalan and dacarbazine (DTIC).
Edwards MJ; Boddie AW; Ames FC; McBride CM
South Med J; 1989 Aug; 82(8):985-7, 989. PubMed ID: 2762904
[TBL] [Abstract][Full Text] [Related]
32. The effect of regional perfusion treatment on recurrent melanoma of the extremities.
Hansson JA; Simert G; Vang J
Acta Chir Scand; 1977; 143(1):33-9. PubMed ID: 855620
[TBL] [Abstract][Full Text] [Related]
33. [Various aspects of treatment of primary melanoblastoma of the extremities by regional perfusion].
Schraffordt Koops H; Eibergen R; Oldhoff J; van der Ploegen E; Vermey A
Ned Tijdschr Geneeskd; 1975 Nov; 119(45):1746-53. PubMed ID: 1214883
[No Abstract] [Full Text] [Related]
34. Melanoma-in-transit presenting as panniculitis.
Cotton J; Armstrong DJ; Wedig R; Hood AF
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):876-8. PubMed ID: 9810920
[TBL] [Abstract][Full Text] [Related]
35. Hyperthermic isolation-perfusion with melphalan, a preliminary appraisal of local and general effects in malignant melanoma.
Lejeune FJ; Mathieu M; Kenis Y
Tumori; 1977; 63(3):289-98. PubMed ID: 898296
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.
Sutherland CM; Mather FJ; Krementz ET
Surg Gynecol Obstet; 1987 Feb; 164(2):111-8. PubMed ID: 3810424
[TBL] [Abstract][Full Text] [Related]
37. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
Olofsson Bagge R; Mattsson J; Hafström L
Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
[TBL] [Abstract][Full Text] [Related]
38. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
39. To perfuse or not to perfuse? A retrospective comparative study to evaluate the effect of adjuvant isolated regional perfusion in patients with stage I extremity melanoma with a thickness of 1.5 mm or greater.
Franklin HR; Schraffordt Koops H; Oldhoff J; Czarnetzki BM; Macher E; Kroon BB; Welvaart K; van der Velden JW; van Dijk E; van der Esch EP
J Clin Oncol; 1988 Apr; 6(4):701-8. PubMed ID: 3357008
[TBL] [Abstract][Full Text] [Related]
40. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
